Italia markets close in 4 hours 3 minutes

Valneva SE (0OB3.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
3,3700-0,0660 (-1,92%)
In data: 11:40AM BST. Mercato aperto.
Schermo intero
Chiusura precedente3,4360
Denaro0,0000 x 0
Domanda0,0000 x 0
Min-Max giorno3,3700 - 3,5900
Intervallo di 52 settimane2,8190 - 7,8420
Media Volume61.823
Beta (mensile su 5 anni)0,97
Rapporto PE (ttm)N/D
EPS (ttm)-0,7060
Prossima data utili13 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Valneva to Present on Chikungunya at Several Leading Scientific Conferences

    Saint-Herblain (France), October 11, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today it will present on the mosquito-borne chikungunya disease at several leading scientific conferences during the fourth quarter of 2023. At IDWeek, the annual meeting of the Infectious Diseases Society of America (IDSA), Valneva will support the roundtable discussion “Chikungunya is an Increasing Global Threat: The Need for Better Protection” taking place on Octo

  • GlobeNewswire

    VALNEVA - Declaration of shares and voting rights: September 30, 2023

    VALNEVA Declaration of shares and voting rightsSeptember 30, 2023__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: October 5, 2023 Number of shares composing the share capital of ValnevaTotal number of voting rights including suspended voting rights*Description of the changeDate on which this change

  • GlobeNewswire

    Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32 Million

    Saint Herblain (France), September 25, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32 million contract with the United States (U.S.) Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO®. Under this new one-year contract, the DoD will buy a minimum of $32 million worth of IXIARO® vaccines and has the possibility to purchase additional doses during the coming twelve months. Delive